Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Lupus Erythematosus, Systemic 1Infectious Mononucleosis 1Infections 1Fatigue Syndrome, Chronic 1Epstein-Barr Virus Infections 1

Interventions

ziprasidone 1tocilizumab 1talquetamab 1idecabtagene vicleucel 1golimumab 1gilteritinib 1anifrolumab 1Zolpidem 1X-Rays 1Wearable Electronic Devices 1Watchful Waiting 1Warfarin 1Vital Signs 1Vecuronium Bromide 1Vancomycin 1Tumor Necrosis Factor Inhibitors 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sevelamer 1Rocuronium 1Rituximab 1Procalcitonin 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Infections × Procalcitonin × Clear all
NCT05127980 2025-02-25

Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection

University Hospital, Basel, Switzerland

Recruiting
80 enrolled

Infections, Infectious Mononucleosis, Lupus Erythematosus, Systemic, Fatigue Syndrome, Chronic, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡